+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Becker Muscular Dystrophy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767621
  • Report
  • 100 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Armgo Pharma Inc
  • Cardero Therapeutics Inc
  • Cardoz AB
  • Italfarmaco Holding SpA
  • Milo Biotechnology LLC
  • OPIS srl
  • MORE
The global clinical trial report- “2019 Becker Muscular Dystrophy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Becker Muscular Dystrophy. It presents in-depth analysis of Becker Muscular Dystrophy clinical trials across markets and companies. The research work is for providing complete understanding into trends in Becker Muscular Dystrophy.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Becker Muscular Dystrophy clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Becker Muscular Dystrophy

The research work is prepared through extensive and continuous research on Becker Muscular Dystrophy trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Becker Muscular Dystrophy patients are identified
  • The report includes panorama of Becker Muscular Dystrophy clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Becker Muscular Dystrophy clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Armgo Pharma Inc
  • Cardero Therapeutics Inc
  • Cardoz AB
  • Italfarmaco Holding SpA
  • Milo Biotechnology LLC
  • OPIS srl
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Becker Muscular Dystrophy Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Becker Muscular Dystrophy Clinical Trials by Region
2.2.2 Average Enrollment of Becker Muscular Dystrophy Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Becker Muscular Dystrophy Treatment, 2019

3. Region wise Becker Muscular Dystrophy Clinical Trials
3.1 Asia Pacific Becker Muscular Dystrophy Clinical Trials by Country
3.2 Europe Becker Muscular Dystrophy Clinical Trials by Country
3.3 North America Becker Muscular Dystrophy Clinical Trials by Country
3.4 Middle East and Africa Becker Muscular Dystrophy Clinical Trials by Country
3.5 South and Central America Becker Muscular Dystrophy Clinical Trials by Country

4. Becker Muscular Dystrophy Clinical Trial Trends
4.1 Start Year wise Becker Muscular Dystrophy Clinical Trials
4.2 Phase wise Becker Muscular Dystrophy Clinical Trials
4.3 Trial Status wise Becker Muscular Dystrophy Clinical Trials
4.4 Trial Type wise Becker Muscular Dystrophy Clinical Trials

5. Becker Muscular Dystrophy Average Enrollment Trends
5.1 Average Enrollment in Becker Muscular Dystrophy Trials by Year
5.2 Average Enrollment in Becker Muscular Dystrophy Trials by Phase
5.3 Average Enrollment in Becker Muscular Dystrophy Trials by Status
5.4 Average Enrollment in Becker Muscular Dystrophy Trials by Type of Trial

6. Companies Participating in Becker Muscular Dystrophy Clinical Trials
6.1 Becker Muscular Dystrophy Trials by Sponsor Type
6.2 Becker Muscular Dystrophy Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Becker Muscular Dystrophy Trials- Phase 1
7.2 Becker Muscular Dystrophy Trials- Phase 2
7.3 Becker Muscular Dystrophy Trials- Phase 3
7.4 Becker Muscular Dystrophy Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Becker Muscular Dystrophy Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Becker Muscular Dystrophy Clinical Trials and Enrolment
Figure 5: Europe - Country wise Becker Muscular Dystrophy Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Becker Muscular Dystrophy Clinical Trials and Enrolment
Figure 7: North America - Country wise Becker Muscular Dystrophy Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Becker Muscular Dystrophy Clinical Trials and Enrolment
Figure 9: Becker Muscular Dystrophy Clinical Trials by Phase
Figure 10: Becker Muscular Dystrophy Clinical Trials by Trial Status
Figure 11: Becker Muscular Dystrophy Clinical Trials by Type
Figure 12: Becker Muscular Dystrophy Clinical Trials by Sponsor Type
Figure 13: Becker Muscular Dystrophy Clinical Trials by Leading Sponsors
Figure 14: Becker Muscular Dystrophy Average Enrollment by Phase
Figure 15: Becker Muscular Dystrophy Average Enrollment by Trial Status
Figure 16: Becker Muscular Dystrophy Average Enrollment by Type
Figure 17: Becker Muscular Dystrophy- Average Enrolment by Type of Sponsors
Figure 18: Becker Muscular Dystrophy- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Becker Muscular Dystrophy Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Becker Muscular Dystrophy Clinical Trials and Enrolment
Table 5: Europe - Country wise Becker Muscular Dystrophy Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Becker Muscular Dystrophy Clinical Trials and Enrolment
Table 7: North America - Country wise Becker Muscular Dystrophy Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Becker Muscular Dystrophy Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Becker Muscular Dystrophy Average Enrollment by Phase
Table 15: Becker Muscular Dystrophy Average Enrollment by Trial Status
Table 16: Becker Muscular Dystrophy Average Enrollment by Type
Table 17: Becker Muscular Dystrophy- Average Enrolment by Type of Sponsors
Table 18: Becker Muscular Dystrophy- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Armgo Pharma Inc
  • Cardero Therapeutics Inc
  • Cardoz AB
  • Catabasis Pharmaceuticals Inc
  • Italfarmaco Holding SpA
  • Milo Biotechnology LLC
  • OPIS srl
  • Pfizer Inc
  • PTC Therapeutics Inc
  • Sanofi
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4767621
Adroll
adroll